Jaguar Health Announces Selection of Investment Bank and Nominated Advisor for Proposed Merger of the Dragon SPAC and Napo EU, Jaguar's Italian SubsidiaryAccesswire • 03/30/21
Jaguar Health Signs Definitive Agreement for $5 Million Non-dilutive Financing Transaction Involving Sale of Royalty Rights Related to Future Potential Crofelemer (Mytesi) COVID-related Indication Revenue StreamAccesswire • 03/09/21
Jaguar Health Enters Binding Term Sheet for $5 Million Non-dilutive Financing Transaction Involving Sale of Royalty Rights Related to Future Potential Crofelemer (Mytesi) COVID-related Indication Revenue StreamAccesswire • 03/05/21
Jaguar Health In MoU With Dragon SPAC As Its Subsidiary Seeks Approval For Crofelemer In EuropeBenzinga • 02/18/21